News

Astellas Pharma Europe has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMEA) for telavancin. Telavancin, a bactericidal, once-daily injectable lipoglycopeptide antibiotic, is meant for

Eisai and TSD Japan has entered into a license and joint development agreement for the development of denileukin diftitox (generic name) in Japan. Under the terms of the

Smiths Medical has been selected for a $10m contract from the US Department of Health and Human Services (HHS) for safety hypodermic syringes. The award is part of

The Society of Chemical Manufacturers and Affiliates (SOCMA) has reported that the FDA has responded to its citizen’s petition after four years, calling on the agency to do

Zogenix and Desitin Pharmaceuticals (Desitin) have reported that Desitin has filed for European regulatory approval of Sumavel DosePro (sumatriptan injection) needle-free delivery system. Reportedly, the announcement follows successful

AstraZeneca has withdrawn the regulatory submissions for the use of Zactima (vandetanib) 100mg in combination with chemotherapy in patients with advanced non-small cell lung cancer (NSCLC), from FDA

Cyclacel Pharmaceuticals (Cyclacel) has reported topline survival data for the primary endpoint of the phase 2 study of sapacitabine. It is intended for the treatment of elderly patients

The National Institutes of Health (NIH) has awarded Excelimmune a Small Business Innovation Research (SBIR) grant to support research aimed at developing new treatments for Clostridium difficile (C.

NCKU has signed a Technology Transfer Agreement with Vedan International. The agreement marks a successful transfer of NCKU’s microalgal DHA (docosahexaenoic acid) production technology, developed by Huey-Lang Yang’s